Zuellig Pharma

AMGEN BIOPHARMACEUTICALS MALAYSIA SDN BHD

Featured products of Amgen
adalimumab
Packing/Price
1's2 × 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
adalimumab
Packing/Price
(pre-filled autoinjector) 4 × 1's6 × 1's (pre-filled autoinjector) 2 × 1's2 × 1's (pre-filled autoinjector) 1's4 × 1's (pre-filled autoinjector) 6 × 1's1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
blinatumomab
Packing/Price
((single-dose)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX07 - blinatumomab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
romosozumab
Packing/Price
2 × 1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX06 - romosozumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
carfilzomib
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG02 - carfilzomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
sotorasib
Packing/Price
7 × 8's30 × 8's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XX73 - sotorasib : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.
bevacizumab
Packing/Price
4 mL x 1's16 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
pegfilgrastim
Packing/Price
0.6 mL x 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
filgrastim
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
filgrastim
Packing/Price
5 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
denosumab
Packing/Price
1 mL x 1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
evolocumab
Packing/Price
((auto-injector)) 1's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.
panitumumab
Packing/Price
5 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Distributed by Zuellig Pharma
adalimumab
Packing/Price
1's2 × 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
adalimumab
Packing/Price
(pre-filled autoinjector) 4 × 1's6 × 1's (pre-filled autoinjector) 2 × 1's2 × 1's (pre-filled autoinjector) 1's4 × 1's (pre-filled autoinjector) 6 × 1's1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
blinatumomab
Packing/Price
((single-dose)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX07 - blinatumomab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
romosozumab
Packing/Price
2 × 1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX06 - romosozumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
carfilzomib
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG02 - carfilzomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
sotorasib
Packing/Price
7 × 8's30 × 8's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XX73 - sotorasib : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.
bevacizumab
Packing/Price
4 mL x 1's16 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
pegfilgrastim
Packing/Price
0.6 mL x 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
filgrastim
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
filgrastim
Packing/Price
5 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
denosumab
Packing/Price
1 mL x 1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
evolocumab
Packing/Price
((auto-injector)) 1's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.
panitumumab
Packing/Price
5 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in